PMID- 19889049 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20110714 LR - 20200929 IS - 1386-6346 (Print) IS - 1386-6346 (Linking) VI - 39 IP - 4 DP - 2009 Apr TI - HBcAg-pulsed dendritic cell vaccine induces Th1 polarization and production of hepatitis B virus-specific cytotoxic T lymphocytes. PG - 355-65 LID - 10.1111/j.1872-034X.2008.00468.x [doi] AB - AIM: Dendritic cells (DCs) pulsed with HBsAg efficiently reverse the immune tolerance to hepatitis B virus (HBV) and induce HBV-specific cytotoxic T lymphocyte (CTL) responses in transgenic mice and healthy volunteers. However, it is not clear whether HBV core antigen (HBcAg)-pulsed DCs can effectively induce CD4(+) helper T cells polarization into Th1, which contribute to the induction and maintenance of HBV-specific CD8(+) T cells in chronic hepatitis B (CHB) patients. To address this issue, we conducted this study and investigated whether HBcAg-pulsed DCs could polarize Th1 cells and induce an HBcAg-specific CTL response. METHODS: HBcAg-pulsed DCs were generated from 21 CHB patients. The capacity of the HBcAg-pulsed DC vaccine to stimulate CD4(+) and CD8(+) T cells to produce IFN-gamma and IL-4 was estimated by intercellular cytokine staining, and the HBcAg-pulsed DCs derived from 10 humam leucocyte antigen (HLA)-A2(+) CHB patients were tested for the induction of HBV-specific CTLs from autologous T cells by pentamer staining. The cytotoxicity of these CTLs was evaluated in vitro by flow cytometry. RESULTS: The HBcAg-pulsed DCs derived from CHB patients exhibited a stronger capacity to stimulate autologous CD4(+) and CD8(+) T cells to release IFN-gamma rather than IL-4, which could induce HBV core 18-27 specific CTLs, suggesting a specific cytotoxicity against T2 cells that had been loaded with the HBV core 18-27 peptide in vitro. CONCLUSION: HBcAg-pulsed DC vaccine derived from CHB patients efficiently induced autologous T cell polarization to Th1 and generation of HBV core 18-27 specific CTLs. FAU - Chen, Weiwei AU - Chen W AD - Center for Clinical Laboratory, Bijing Institute of Infectious Diseases, Beijing, China. FAU - Shi, Ming AU - Shi M FAU - Shi, Feng AU - Shi F FAU - Mao, Yuanli AU - Mao Y FAU - Tang, Zirong AU - Tang Z FAU - Zhang, Bin AU - Zhang B FAU - Zhang, Hui AU - Zhang H FAU - Chen, Liangen AU - Chen L FAU - Chen, Liming AU - Chen L FAU - Xin, Shaojie AU - Xin S FAU - Wang, Fu-Sheng AU - Wang FS LA - eng PT - Journal Article PL - Netherlands TA - Hepatol Res JT - Hepatology research : the official journal of the Japan Society of Hepatology JID - 9711801 EDAT- 2009/11/06 06:00 MHDA- 2009/11/06 06:01 CRDT- 2009/11/06 06:00 PHST- 2009/11/06 06:00 [entrez] PHST- 2009/11/06 06:00 [pubmed] PHST- 2009/11/06 06:01 [medline] AID - HEP468 [pii] AID - 10.1111/j.1872-034X.2008.00468.x [doi] PST - ppublish SO - Hepatol Res. 2009 Apr;39(4):355-65. doi: 10.1111/j.1872-034X.2008.00468.x.